DKK1
Reaktivität: Human
WB, ELISA
Wirt: Maus
Monoclonal
2H2
unconjugated
Applikationshinweise
Peptide ELISA: 1/128000. Western blot: 1 - 3 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
0,5 mg/mL
Buffer
Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Niessner, Kosnopfel, Sinnberg, Beck, Krieg, Wanke, Lasithiotakis, Bonin, Garbe, Meier: "Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1." in: Experimental dermatology, Vol. 26, Issue 7, pp. 598-606, (2018) (PubMed).
DKK1 is an inhibitor of the Wnt signaling pathway. Elevated levels of DKK1 in bone marrow plasma and peripheral blood is associated with the presence of osteolytic bone lesions in patients with multiple myeloma.Synonyms: DKK-1, DKK1, Dickkopf-related protein 1, SK